File image of a nurse holding vials of AstraZeneca vaccine towards COVID-19
| Photo Credit: AP
AstraZeneca stated on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” because the pandemic.
The firm additionally stated it might proceed to withdraw the vaccine Vaxzevria’s advertising and marketing authorisations inside Europe.
“As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines,” the corporate stated, including that this had led to a decline in demand for Vaxzevria, which is not being manufactured or provided.
According to media experiences, the Anglo-Swedish drugmaker has beforehand admitted in courtroom paperwork that the vaccine causes side-effects such as blood clots and low blood platelet counts.
The agency’s utility to withdraw the vaccine was made on March 5 and got here into impact on May 7, in accordance to the Telegraph, which first reported the event.
London-listed AstraZeneca started transferring into respiratory syncytial virus vaccines and weight problems medication by a number of offers final yr after a slowdown in progress as COVID-19 medication gross sales declined.
